Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02740361 · ClinicalTrials.gov registry record · NA
Online Program to Reduce Depression in MS
A NA study of Multiple Sclerosis, sponsored by Charite University, Berlin, Germany.
- Completed
- Registry status
- NA
- Development phase
- 279
- Enrollment target
- 5
- Study locations
NCT02740361: Completed NA study of Multiple Sclerosis, sponsored by Charite University, Berlin, Germany.
NCT02740361 is a NA study of Multiple Sclerosis that has completed, run by Charite University, Berlin, Germany. The registered enrollment target is 279 participants, below the 584-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (52% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02740361, a NA study of Multiple Sclerosis, has completed, sponsored by Charite University, Berlin, Germany.
- COMPLETED
- Registry status
- NA
- Development phase
- 279 participants
- Enrollment target
- 5
- Study locations
Study Summary
This is an international, multicenter, randomized controlled trial of an internet-based CBT intervention for depression (Deprexis) conducted in five MS centers in the US and Germany. The trial consists of a three-arm primary trial phase and an extension phase targeted at maintenance.
Conditions Studied
Interventions
- BEHAVIORAL Deprexis, DeprexisPlus
Study Locations (5)
California
- Cedars-Sinai Medical Center - Los Angeles
Kansas
- University of Missouri, Kansas City - Kansas City
Pennsylvania
- Penn State University - State College
Hamburg
- Universitätsklinikum Hamburg-Eppendorf - Hamburg
State of Berlin
- Charité University - Berlin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 279 participants |
| Start Date | 2017-02-15 |
| Est. Completion | 2021-05-01 |
| Phase | NA |
What the finished NCT02740361 record still lists
NCT02740361 is an interventional study that assigns participants to a tested intervention. The registered 279 participants enrollment target is mid-sized for trials with a published cap, below the 584-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (52% lower).
The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which Deprexis, DeprexisPlus is the first listed.
NCT02740361 lists 5 locations in 5 states (California, Kansas, Pennsylvania).
Frequently Asked Questions
What is clinical trial NCT02740361 about?
NCT02740361 is a clinical study titled "Online Program to Reduce Depression in MS". This is an international, multicenter, randomized controlled trial of an internet-based CBT intervention for depression (Deprexis) conducted in five MS centers in the US and Germany. The trial consists of a three-arm primary trial phase and an extension phase targeted at maintenance.
What is the current status of trial NCT02740361?
This trial is currently completed. It is a NA study. The enrollment target is 279 participants. The study started on 2017-02-15. Estimated completion is 2021-05-01.
What conditions does trial NCT02740361 study?
This clinical trial studies the following conditions: Multiple Sclerosis.
What interventions are being tested in trial NCT02740361?
The interventions under investigation include: Deprexis, DeprexisPlus (BEHAVIORAL).
Who is sponsoring clinical trial NCT02740361?
This trial is sponsored by Charite University, Berlin, Germany, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02740361 being conducted?
This trial has 5 study locations across California, Kansas, Pennsylvania, Hamburg, State of Berlin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02740361's enrollment target sits among peer trials
279 64th of 315 higher than 252 of 315 other Multiple Sclerosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Multiple Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Prepare the Mind: Can Coaching in Goal-directed Behaviour Increase the Success of Cognitive Rehabilitation in People With MS?
RECRUITING · NA
-
Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis
RECRUITING · NA
-
Intermittent Hypoxia in Persons With Multiple Sclerosis
RECRUITING · NA
-
Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS
RECRUITING · NA
-
Central Vein Sign in Multiple Sclerosis Extension Study
RECRUITING · NA
-
Effects of Torso Weighting on Muscle Activation During Balance Tests in Individuals With and Without Multiple Sclerosis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04783857 · 279 participants · Phase 4
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
- NCT05407324 · 279 participants · Phase 2
Dazucorilant in Patients With Amyotrophic Lateral Sclerosis
- NCT06299748 · 279 participants
A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
- NCT06582784 · 279 participants · NA
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI